Follow The Filings

IMRX Immuneering

Immuneering earnings company data as of 4:48 AM ET 10/23

Limited consensus data for this ticker (thin coverage or data-plan limits). Dates may be company-announced rather than sell-side consensus. Calendar and recent prints remain the primary lens when available.

Scheduled

1 period, newest first, nothing reported yet. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 11 Nov EPS — — —
Rev — — —

Insider trades

Open-market buys and sales by IMRX's executives, directors and 10% owners in the last 12 months, from their Form 4s

All IMRX insider trades
  • $270K bought by 6 insiders
  • None no sales outside a trading plan
  • None no planned (10b5-1) sales
  1. Benjamin J. Zeskind CEO
    Buy
    $11K 2,400 shares at $4.56 +0.1% to stake
    Traded Jun 23 Filed Jun 24
    ↗
  2. Brett Matthew Hall Chief Scientific Officer
    Buy
    $25K 6,035 shares at $4.15 +1.6% to stake
    Traded Jun 15 Filed Jun 16
    ↗
  3. Harold Eugene Brakewood Chief Business Officer
    Buy
    $25K 5,250 shares at $4.76 +91% to stake
    Traded Jan 16 Filed Jan 21
    ↗
  4. Thomas J. Schall Director
    Buy
    $101K 21,645 shares at $4.67 +41% to stake
    Traded Jan 15 Filed Jan 20
    ↗
  5. Brett Matthew Hall Chief Scientific Officer
    Buy
    $11K 2,298 shares at $4.57 +0.6% to stake
    Traded Jan 15 Filed Jan 16
    ↗
  6. Leah R Neufeld Chief People Officer
    Buy
    $11K 2,626 shares at $4.15 +11% to stake
    Traded Jan 13 Filed Jan 15
    ↗
  7. Peter Feinberg Director
    Buy
    $87K 20,000 shares at $4.35 +17% to stake
    Traded Jan 12 Filed Jan 14
    ↗

Also filed in the last 12 months, not counted as buying or selling: 1 stock grant.

SEC filings

Recent issuer filings from EDGAR, 17 shown.

Filed Form Detail Links
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
SCHEDULE 13G — Filing Doc
8-K 5.02 Filing Doc
8-K 5.07 Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc
DEF 14A Filing Doc
DEFA14A Filing Doc
8-K 2.02,9.01 Filing Doc
10-K Filing Doc
SCHEDULE 13G/A — Filing Doc
SCHEDULE 13G/A — Filing Doc
8-K 8.01 Filing Doc
8-K 2.02,9.01 Filing Doc
10-Q Filing Doc

Source: SEC EDGAR submissions, updated 6 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.